Navigation Links
Webcast Alert: Heska Announces Third Quarter 2008 Earnings Conference Call Webcast
Date:10/31/2008

LOVELAND, Colo., Oct. 31 /PRNewswire-FirstCall/ -- Heska Corporation (Nasdaq: HSKA) announces the following Webcast:
(Logo: http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO)

What: Heska Corporation Invites You to Join Its Third Quarter 2008

Earnings Conference Call on the Web

When: Monday, November 10, @ 9:00 a.m. (MST]

Where: http://www.heska.com (click on the Q3 2008 Earnings Call link on

the front page of this website)

How: Live over the Internet -- Simply log on to the web at the

address above.

Contact: Contact -- General Information: Yvonne Mulley, 970-493-7272

yvonne.mulley@heska.com. Media Contact: Jason Napolitano,

970-493-7272 jason.napolitano@heska.com.

If you are unable to participate during the live webcast, the call will be archived at http://www.heska.com until November 24, 2008. To access the replay, click on the Q3 2008 Earnings Call link on the front page of this website.

Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products. Heska's state-of-the-art offerings to its customers include diagnostic and monitoring inst
'/>"/>

SOURCE Heska Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Webcast Alert: Kaiser Permanente Residency Program Open House
2. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
3. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
4. Nuvelo Announces Upcoming Conference Calls, Webcasts and Conference Participation
5. Webcast Alert: Heska Announces Third Quarter 2007 Earnings Conference Call Webcast
6. Exelixis Announces September 18 Webcast of Presentation at the Bank of America 2007 Investment Conference
7. Live Webcast With President George H.W. Bush as Bono and DATA Are Honored With National Constitution Centers 2007 Liberty Medal in Historic Philadelphia
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Rohm and Haas to Webcast Presentation at Credit Suisse Chemicals Conference
10. Schering-Plough Schedules Conference Call and Webcast for 2007 Third Quarter Earnings
11. Par Invites Public to Listen to Webcast of its September 28 Analysts Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...PRNewswire-FirstCall/ -- Gen-Probe Incorporated (N...er Jaffray Health Care Conference today at 2:30 p....be webcast live and may be accessed through a link...t www.gen-probe.com . The webcast will be availab...en-Probe ,, Gen-Probe Incorporated is a globa...
(Date:12/2/2009)...ewswire/ -- A randomized, controlled study compari...vasive treatment called percutaneous disc decompre...le both treatments help patients in the short run,...p to two years later. Results of the study, the fi...l meeting of the Radiological Society of North Ame...
(Date:12/2/2009)...2 LeapFrog Investments has announc... in AllLife, the innovative South African insurer ...nvestment brings together LeapFrog, the leading mi...Africa,s most innovative insurance businesses. The..., "AllLife has developed a distinctive and profit...
(Date:12/2/2009)...sound of suspicious areas of the breast, including...ernative to invasive biopsies for women under age ...nted today at the annual meeting of the Radiologic...ming high-quality breast ultrasound, we can reduce...agnostic procedures in young women," said senior a...
(Date:12/2/2009)...ale clinical trial presented today at the annual m...a (RSNA) provide the first strong evidence of the ...ith dense breasts who are at elevated risk for bre...MRI is highly sensitive in depicting early breast ...ltrasound in addition to mammography significantly...
Breaking Medicine News(10 mins):Health News:Gen-Probe to Webcast Presentation at the 21st Annual Piper Jaffray Health Care Conference Today 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 2Health News:LeapFrog Invests $6M in AllLife, Innovative African HIV and Diabetes Insurer 3Health News:Targeted breast ultrasound can reduce biopsies for women under 40 2Health News:Annual screening with breast ultrasound or MRI could benefit some women 2
...8 Kensey Nash Corporation (Nasdaq: KNSY ) today...d a stock repurchase. The new program allows the ...its issued and outstanding shares of Common Stock ...he recent trading price of our stock, we believe w...
...ey asks adults what lessons they learned from elde...e; top response was gratitude; elders say that sim...r key lessons: perseverance, importance of family ...conjunction with national conference Aging in Amer...
...Cells to Be Harvested and Transplanted Into the Ja...al Implantation , , RANCHO SANTA MARGARITA, Calif...o restore his infectious grin, but to attach an im...ental, will make Morgan,s wish come true through t...
...., March 18 In the eight years since its inceptio...nter in Evergreen Park, Illinois, has developed a ...omeo, R.N., CNOR, CRNFA, the bariatric surgery pro...t who undergoes weight-loss surgery at the Little ...
... March 18 Ribbit Marketing, Inc. is hosting a tel...for North Carolina college film students to increa...re being requested for PSAs showcasing www.NCHeal...lina. , , The PSA contest will give students the...
...f Sales to the Northern California Chapter of the ...rch 18 Presto Services Inc. announces a specia...Month in March to raise funds and awareness to fin... 5% of the retail value ($7.49 each) to the North...
Other Medicine News:Health News:Kensey Nash Announces 600,000 Share Stock Repurchase Program 2Health News:Kensey Nash Announces 600,000 Share Stock Repurchase Program 3Health News:New Survey: Top Lesson from Seniors About Economic Worries? Gratitude Trumps Fear 2Health News:Southern California Dentist First on the West Coast to Perform Concentrated Stem Cell Transplant for Dental Implant Procedure 2Health News:Southern California Dentist First on the West Coast to Perform Concentrated Stem Cell Transplant for Dental Implant Procedure 3Health News:Chicago-area ASBS Bariatric Surgery Center of Excellence Provides Personalized Care Like No Other Weight-Loss Surgery Program 2Health News:Ribbit Marketing Hosts Contest for NC Film Students 2Health News:Presto Announces Donation Program to Help Find the Cure for Multiple Sclerosis 2Health News:Presto Announces Donation Program to Help Find the Cure for Multiple Sclerosis 3
(Date:12/2/2009)... , EAST HANOVER, N.J., Dec. 2 N... late-breaking presentation on Tasigna® (nilo...d leukemia, demonstrate the strength of the compan...patients. ,, The new data, at the 51st America...xposition, highlight the company,s current therapi...
(Date:12/1/2009)...MECULA, Calif., Dec. 1 P...rd: PSTX) announced today that it has appointed Ma...ncial Officer, Treasurer and Corporate Secretary, ...ce 2008. Prior to joining Patient Safety Technolo...hief Financial Officer, Treasurer and Corporate Se...
(Date:12/1/2009)...ONDO BEACH, Calif., Dec. 1 Reprodu... Elective Single Embryo Transfer (eSET) Encouragem...atients with good embryo quality and a good progno... twins by transferring a single embryo. ,, The ...today is reducing the number of multiple pregnanci...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Patient Safety Technologies, Inc. Appoints Marc L. Rose, CPA (PA), Chief Financial Officer 2Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 1CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 2CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology 54843 3eDiets com 28R 29 Granted Continued Listing by NASDAQ Panel 54840 1eDiets com 28R 29 Granted Continued Listing by NASDAQ Panel 54840 2Are You Connected 3F AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 54836 1Are You Connected 3F AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 54836 2Are You Connected 3F AIM and GASICORP Expand Global Reach Through Landmark Strategic Alliance 54836 3
...ggest Clinically Meaningful Primary Endpoint for C...tional World Muscle Society,Congress -, SOUTH PLA...TC) today announced promising findings in patients... at the 13th International World Muscle Society,(W...assessing the utility,of the 6-minute walk test (6...
...ent inhibitor to be tested in AMD patients, LOUIS...privately held biotechnology company developing me...egeneration (AMD) announced today that the,Company...positive safety,results in its Phase I study. POT-...complement activation cascade that could otherwise...
Other Medicine Technology:PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 5Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2
...c has been a key participant in the area of blood ...us Medtronic autotransfusion systems allowed clini...latelets, as well as to determine requirements for...ch plasma (PRP) for a small amount of autologous b...
RX HERCULINK® PLUS Biliary Stent System
Response Catheter
Fast-Cath™ Guiding Introducers
Medicine Products: